You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms, Thrombosis, hypocoagulability

Showing 1 - 25 of 7,452
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Thrombosis, Coagulation Disorder Trial in Nice (Blood sample analysis)

Completed
  • Neoplasms
  • +2 more
  • Blood sample analysis
  • Nice, France
    Centre Antoine Lacassagne
Dec 12, 2022

Monocytes Sub-populations in Thrombosis Associated With

Recruiting
  • Myeloproliferative Neoplasm
  • 1 additional tube of blood
  • Bordeaux, France
  • +4 more
Nov 30, 2022

Thrombosis in Myeloproliferative Neoplasms

Completed
  • Myeloproliferative Neoplasm
  • 2 additional tubes of blood
  • Angers, France
  • +23 more
Aug 17, 2022

Lung Cancer, Stomach Cancer, Breast Cancer Trial in Jinan (Precision grip training, Use maximum strength grip training, Health

Completed
  • Lung Cancer
  • +5 more
  • Precision grip training
  • +2 more
  • Jinan, Shandong, China
    Qianfoshan Hospital
Feb 2, 2023

Cancer-associated Venous Thromboembolism

Recruiting
  • Venous Thromboses
  • Neoplasms
    • Wuhan, China
      Tongji Hospital
    Feb 6, 2023

    Venous Thrombosis, Tumors, Anticoagulant Trial in Kyoto (12-month Edoxaban, 3-month Edoxaban)

    Active, not recruiting
    • Venous Thrombosis
    • +2 more
    • 12-month Edoxaban
    • 3-month Edoxaban
    • Kyoto, Japan
      Department of Cardiovascular Medicine, Kyoto University Graduate
    Aug 16, 2022

    Venous Thromboembolism in Hematologic Malignancy and

    Active, not recruiting
    • Thrombosis, Venous
    • +4 more
      • Toronto, Ontario, Canada
        Federico Carini
      Nov 21, 2022

      Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis

      Active, not recruiting
      • Myeloproliferative Neoplasm
      • +3 more
      • standard of care.
      • (no location specified)
      Sep 14, 2021

      Venous Thrombosis, Tumors Trial in Minneapolis, Columbus, Milwaukee (Heparin, Low-Molecular-Weight, or direct oral

      Completed
      Has Results
      • Venous Thrombosis
      • Neoplasms
      • Heparin, Low-Molecular-Weight, or direct oral anticoagulants
      • Minneapolis, Minnesota
      • +2 more
      Apr 26, 2022

      Deep Vein Thrombosis, Pulmonary Embolus, Colon Cancer Trial (Colon resection)

      Completed
      • Deep Vein Thrombosis, Pulmonary Embolus
      • Colon Cancer
      • Colon resection
      • (no location specified)
      Aug 18, 2023

      Thrombosis in Multiple Myeloma in an University Medical Center

      Recruiting
      • Multiple Myeloma
      • +2 more
      • Multiple myeloma
      • Groningen, Netherlands
        University Medical Center Groningen
      Sep 12, 2022

      Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Seoul (PBT and atezolizumab/bevacizumab)

      Recruiting
      • Hepatocellular Carcinoma
      • Portal Vein Thrombosis
      • PBT and atezolizumab/bevacizumab
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Nov 15, 2022

      Myeloproliferative Tumor, Splanchnic Vein Thrombosis, JAK2 V617 Trial in London (Drugs, procedures)

      Enrolling by invitation
      • Myeloproliferative Neoplasm
      • +2 more
      • Drugs, procedures
      • London, United Kingdom
        Royal Free London Hospital
      Jul 29, 2021

      Deep Venous Thrombosis, Colonic Cancer Trial in São Paulo (Rivaroxaban 10 MG)

      Not yet recruiting
      • Deep Venous Thrombosis
      • Colonic Cancer
      • Rivaroxaban 10 MG
      • São Paulo, SP, Brazil
        Hospital do Servidor Público Estadual de São Paulo
      Mar 21, 2022

      Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

      Not yet recruiting
      • Renal Cancer
      • +3 more
      • Aurora, Colorado
        University of Colorado Cancer Center
      Jul 24, 2023

      Pancreas Cancer, Pancreas Tumor, Surgery Trial (enoxaparin/tinzaparin/dalteparin)

      Not yet recruiting
      • Pancreas Cancer
      • +4 more
      • (no location specified)
      Feb 8, 2022

      Real-World Mapping Antithrombotic Regimens in MM Patients on

      Not yet recruiting
      • Multiple Myeloma
      • Diagnosis
        • (no location specified)
        Aug 31, 2023

        Central Venous Catheter-related Complications in Patients Under

        Not yet recruiting
        • Central Venous Catheter Thrombosis
        • +3 more
        • central venous catheter
        • (no location specified)
        Jul 8, 2022

        Blood Clots and Bleeding in Hematological Malignancies, HAT

        Recruiting
        • Acute Leukemia
        • +7 more
        • Biospecimen Collection
        • Electronic Health Record Review
        • Scottsdale, Arizona
          Mayo Clinic in Arizona
        Jun 17, 2022

        Lymphoma, Malignant Solid Tumor, Plasma Cell Myeloma Trial in Portland (Xisomab 3G3)

        Recruiting
        • Lymphoma
        • +2 more
        • Xisomab 3G3
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Feb 28, 2022

        Thrombosis Trial in Assiut (myeloproliferative neoplasms)

        Recruiting
        • Thrombosis
        • myeloproliferative neoplasms
        • Assiut, Egypt
          Clinical Hematology Unit
        Feb 18, 2021

        Tumors Malignant, Surgery, Venous Thromboembolism Trial in Hamilton (Apixaban 2.5 milligram)

        Completed
        • Neoplasms Malignant
        • +4 more
        • Apixaban 2.5 milligram
        • Hamilton, Ontario, Canada
        • +1 more
        Apr 14, 2022

        Venous Thrombosis, Tumors, Anticoagulants Trial in Kyoto (Long DOAC, Short DOAC)

        Recruiting
        • Venous Thrombosis
        • +2 more
        • Long DOAC
        • Short DOAC
        • Kyoto, Japan
          Department of Cardiovascular Medicine, Kyoto University Graduate
        Mar 29, 2022

        Epigenetic Age on Clinic-biological Presentation and Prognosis

        Not yet recruiting
        • Myeloproliferative Neoplasm
        • Assessment of the epigenetic age
        • Bordeaux, France
          CHU de Bordeaux, service Hématologie Biologique
        Aug 28, 2023

        Esophageal Tumors, Thrombosis, Thromboembolism Trial in Aarhus N (Fragmin 5000 UNT in 0.2 ML Prefilled Syringe)

        Recruiting
        • Esophageal Neoplasms
        • +2 more
        • Fragmin 5000 UNT in 0.2 ML Prefilled Syringe
        • Aarhus N, Denmark
          Thrombosis and Haemostasis Research Unit, Department for Clinica
        Sep 23, 2021